China Traditional Chinese Medicine Holdings Co. Limited
CHIZF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $16,509,708 | $18,121,861 | $14,304,242 | $19,052,802 |
| % Growth | -8.9% | 26.7% | -24.9% | – |
| Cost of Goods Sold | $8,653,400 | $8,847,369 | $7,105,790 | $7,223,639 |
| Gross Profit | $7,856,308 | $9,274,492 | $7,198,452 | $11,829,163 |
| % Margin | 47.6% | 51.2% | 50.3% | 62.1% |
| R&D Expenses | $596,007 | $685,632 | $611,831 | $694,441 |
| G&A Expenses | $1,057,664 | $1,043,318 | $944,404 | $974,449 |
| SG&A Expenses | $6,476,935 | $7,446,519 | $5,548,502 | $8,556,412 |
| Sales & Mktg Exp. | $5,419,271 | $6,403,201 | $4,604,098 | $7,581,963 |
| Other Operating Expenses | $447,772 | -$284,936 | -$26,164 | -$127,971 |
| Operating Expenses | $7,520,714 | $7,847,215 | $6,134,169 | $9,122,882 |
| Operating Income | $335,594 | $1,427,277 | $1,064,283 | $2,753,058 |
| % Margin | 2% | 7.9% | 7.4% | 14.4% |
| Other Income/Exp. Net | -$172,485 | -$202,744 | -$224,174 | -$232,778 |
| Pre-Tax Income | $163,109 | $1,224,533 | $840,109 | $2,520,280 |
| Tax Expense | $142,338 | -$171,537 | $119,357 | $396,856 |
| Net Income | $54,067 | $1,285,200 | $764,486 | $1,932,858 |
| % Margin | 0.3% | 7.1% | 5.3% | 10.1% |
| EPS | 0.011 | 0.26 | 0.15 | 0.38 |
| % Growth | -95.9% | 73.3% | -60.5% | – |
| EPS Diluted | 0.011 | 0.26 | 0.15 | 0.38 |
| Weighted Avg Shares Out | 5,035,801 | 5,035,801 | 5,035,801 | 5,035,801 |
| Weighted Avg Shares Out Dil | 5,035,801 | 5,035,801 | 5,035,801 | 5,035,801 |
| Supplemental Information | – | – | – | – |
| Interest Income | $47,677 | $65,257 | $67,269 | $62,576 |
| Interest Expense | $235,772 | $199,045 | $220,695 | $222,029 |
| Depreciation & Amortization | $1,130,224 | $1,133,271 | $1,099,397 | $849,597 |
| EBITDA | $1,529,105 | $2,556,849 | $2,160,201 | $3,591,906 |
| % Margin | 9.3% | 14.1% | 15.1% | 18.9% |